Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast cancer in Greece: An economic evaluation study

BACKGROUND: The objective of our study was to conduct a cost-effectiveness (CE) study of combined everolimus (EVE) and exemestane (EXE) versus the common clinical practice in Greece for the treatment of postmenopausal women with HR+/HER2- advanced breast cancer (BC) progressing on nonsteroidal aroma...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:BMC Health Serv Res
मुख्य लेखकों: Kourlaba, Georgia, Rapti, Vasiliki, Alexopoulos, Athanasios, Relakis, John, Koumakis, Georgios, Chatzikou, Magdalini, Maniadakis, Nikos, Georgoulias, Vassilis
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2015
विषय:
Research Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4524048/
https://ncbi.nlm.nih.gov/pubmed/26239115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-015-0971-4
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन